---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-012521"
form_type: "8-K"
ticker: "CBUS"
cik: "0001705843"
company_name: "Cibus, Inc."
filed_at: "2024-03-21T23:59:59+00:00"
generated_at: "2026-06-04T09:58:28.596226+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cibus Q4 net loss $277M on $249M goodwill impairment; cash $32.7M

## Summary
- Net loss $277.2M ($12.59/share) vs $2.8M prior year, driven by $249.4M non-cash goodwill and intangible impairment.
- Cash $32.7M at Dec 31, 2023; expects to fund operations into early Q3 2024.
- R&D expense $14.2M, SG&A $6.8M, both up significantly from prior year due to merger and headcount.
- Business progress: PSR in Canola transferred to 10 customers; HT traits in Rice with Bayer, Nutrien, Nuseed, Interoc.
- EU Parliament vote supporting new genomic techniques; opened gene editing production facility.

## SEC filing metadata
- accession: 0001628280-24-012521
- form_type: 8-K
- ticker: CBUS
- cik: 0001705843
- company_name: Cibus, Inc.
- filed_at: 2024-03-21T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1705843/000162828024012521/0001628280-24-012521-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1705843/000162828024012521/cbus-20240321.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-012521
- JSON: https://secwatch.observer/filing/0001628280-24-012521.json
- Plain text: https://secwatch.observer/filing/0001628280-24-012521.txt

## Key facts
- Earnings Releases
  Cibus, Inc. reported financial results for the quarter ended December 31, 2023.
  - Period: the quarter ended December 31, 2023
  - Result: reported results
  source text: On March 21, 2024, Cibus, Inc. (the “Company”) announced its financial results for the year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1705843/000162828024012521/0001628280-24-012521-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.